GIVAX, Inc. is a biotech company that is backed by RA Ventures, the venture-focused arm of RA Capital Management, LP. GIVAX is developing novel oral vaccines to eliminate the burden of preventable GI disease in children & adults. Our lead program is a dual pediatric rotavirus / norovirus vaccine.
Company Details
- Employees
- 16
- Founded
- -
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.givax.bio
Givax, Inc. Questions
Givax, Inc.'s website is https://www.givax.bio
Givax, Inc.'s LinkedIn profile is https://www.linkedin.com/company/givax-inc
Givax, Inc. has
16 employees.
View email and phone details for 16
employees at Givax, Inc..
Givax, Inc.'s industry is
Biotechnology Research
Givax, Inc.'s top competitors are
Century Therapeutics, Inc,
Spark Therapeutics, Inc.,
Raven (Ra Ventures),
Integral Molecular,
Ra Capital Management,
Biolabs For Advanced Therapeutics Philadelphia,
Interius Biotherapeutics,
Aum Biotech,
Biocartesian,
Vintabio.
Givax, Inc.'s categories are Biotechnology Research
Givax, Inc.'s founding year is 2021
